Pharmacokinetics and safety of sunitinib malate in subjects with impaired renal function.

Journal of clinical pharmacology

Volumn 50, Issue 4, 2010, Pages 472-481

  Khosravan, Reza ^a   Toh, Melvin ^b   Garrett, May ^b   La Fargue, Joann ^b   Ni, Grace ^b   Marbury, Thomas C ^b   Swan, Suzanne K ^b   Lunde, Norman M ^b   Bello, Carlo L ^b  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INDOLE DERIVATIVE; PYRROLE DERIVATIVE; SUNITINIB;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG EFFECT; FEMALE; FOLLOW UP; HUMAN; KIDNEY FUNCTION TEST; MALE; METABOLIC CLEARANCE RATE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHASE 1 CLINICAL TRIAL; PHYSIOLOGY;

ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; INDOLES; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; PYRROLES;

MLCS; MLOWN;

EID: 77954843443     PISSN: None     EISSN: 15524604     Source Type: Journal    
DOI: 10.1177/0091270009347868     Document Type: Article

References (0)